No Picture
News

Vial adds Dr. Guru Sonpavde of the Dana-Farber Cancer Institute to their Oncology CRO Advisory Board

SAN FRANCISCO, July 31, 2022 /PRNewswire/ — Dr. Guru Sonpavde is the Bladder Cancer Director at the Dana-Farber Cancer Institute, an Associate Professor of Medicine at Harvard Medical School, and a practicing physician. Dr. Sonpavde, along with the ot… […]

No Picture
News

Which drugs may be hit with negotiations if the reconciliation bill passes? Wall St. analysts explain

Beyond the back and forth of whether Democrats’ drug price negotiation plan is necessary to bring down costs, or just a thinly veiled attempt at price controls, the nuts and bolts of the deal mean pharma companies will inevitably see the tail ends of c… […]

No Picture
News

JAMA study finds cancer drug data is still largely unavailable to qualified researchers

As data sharing has become more helpful and relevant to researchers in the past few years, a new report in JAMA Oncology shows that the availability of cancer drugs’ clinical trial data is still lagging for researchers. An audit from Australian researc… […]

No Picture
News

GO2 Foundation for Lung Cancer to Honor Dr. Rafael Rosell with the Bonnie J. Addario Lectureship Award

GO2 Foundation will recognize Dr. Rafael Rosell at the 23rd International Lung Cancer Congress for his global contributions to oncology, particularly in the field of non-small-cell lung cancer SAN CARLOS, Calif. and WASHINGTON, July 29, 2022 /PRNewswir… […]